Kolexia
Morel Aurore Pharmacien
Morel Aurore
Pharmacien
Hôpital Robert-Debré Reims
Reims, France
37 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Psoriasis Effets secondaires indésirables des médicaments Ostéonécrose Pneumopathie infectieuse Hypertension artérielle Bégaiement Poumon éosinophile Maladies de la mâchoire Encéphalite à anticorps anti-récepteur N-méthyl-D-aspartate

Collaborateurs

Voir plus
Trenque Thierry
Trenque Thierry
Maison Blanche, Reims, France
Azzouz Brahim
Azzouz Brahim
Hôpital Robert-Debré Reims, Reims, France
Lepoix Elise
Lepoix Elise
Sce Departemental Incendie Et Secours, Bar-le-Duc, France
Trenque Agathe
Trenque Agathe
CHU Reims, Reims, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Free your mind by Aurore Aurore MOREL QUERON - Apple Podcasts
Apple Podcast   23 septembre 2023
Vogt–Koyanagi–Harada disease following COVID-19 vaccination: A comparative study
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Comparative study of osteonecrosis of the jaw with bisphosphonates and denosumab in two pharmacovigilance database
Abstracts of the 38th International Conference on Pharmacoepidemiology: Advancing Pharmacoepidemiology and Real‐World Evidence for the Global Community, August 26–28, 2022, Copenhagen, Denmark   23 septembre 2022
Anti-NMDA receptor encephalitis and vaccination: A disproportionality analysis.
Frontiers in pharmacology   17 août 2022
Psoriasis risk after beta-blocker exposure: Description of a pharmacovigilance signal.
British journal of clinical pharmacology   06 avril 2022
Immune-mediated necrotizing myopathy with pembrolizumab: a specific neuromuscular entity.
European journal of clinical pharmacology   06 janvier 2022
Track: Pharmacovigilance
Abstracts of the 37th International Conference on Pharmacoepidemiology \u0026amp; Therapeutic Risk Management, Virtual, August 23, 2021   24 août 2021
A sensitization campaign on under-reporting in Pharmacovigilance at the Faculty of Pharmacy
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
Multiple vertebral fractures after denosumab discontinuation
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
Isoniazid and Parkinson's disease treatment: Interaction?
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021